Indian Biotech Industry (2005)

Indian Biotech Industry (2005)

India being on the ‘threshold of biotech revolution’ has 280 biotech and 180 bio suppliers contributing to the total biotech market worth US $100 billion. The country has a global market worth $91 billion and there is scope for cheap R&D through bio-partnering and co-developing technologies mainly with Chinese and American companies. Already the world pharma companies are seeking India to set their research and development centers here. Moreover, to facilitate foreign investment, capital and government policies are being revised.

It has been found that Indian biotech firms are making a strong position, developing business models and improving product commercialization capabilities. With this, India could make a good $5 billion by 2010.

A new market research report, “Indian Biotech Industry (2005)” by RNCOS provides insights into the Indian biotech industry including product estimates, market segmentation, and regulatory mechanisms, pricing policies, patents and opportunities in international venture ship. The report says how in 2004-05, 20 privately helped drug discovery groups have started to operate in India with their business primarily to create innovations and IPR. The biotech industry is likely to draw huge FDI to the Union Government.

The market research report also details the success of the biotech firms in terms of their business profiles, export outlets, financial performances and future plans. It also has the contact details of the major industry associations.

REPORT HIGHLIGHTS:
- Assessment of what is happening in China across the value chain, the organizational structure and, the interaction between Indo-China biotech businesses and research.
- Changes in patent policies and Intellectual Property Rights – A strategic analysis.
- Sales and demand analysis for biotech products in agri-business and clinical studies, 2005-2010.
- An estimate of the recent and future investment programs in Indian biotechnology sector and growth statistics.
- SWOT analysis of Indian biotechnology sector.
- New drafts and policies formulated by National Biotechnology Development Authorities and how it facilitates in private-public partnerships across biotech firms.
- Key profiles and marketing strategies.

REPORT FEATURES:
The market research report “Indian Biotech Industry (2005)” prepared by RNCOS gives a detail analysis of the Indian biotech market scenario, the technological developments and researches. These have been divided into a number of relevant chapters. Chapter 2 giving an introduction is followed by chapter 3 which talks about the changing legal framework of the biotech sector in India mentioning, fiscal incentives, changes in patents acts, plant varieties and Farmers’ Rights Protection Act, 2001 and other regulations for the biotech sector. Chapter 4 gives the state driven initiatives and policies, region wise.

Chapter 5 analyzes the Indian biotechnology market for 2005 in terms of size, demand, industry segments, exports, number of companies & associations, employment opportunities, investments and status of biotech parks. Chapter 6 gives the SWOT analysis; chapter 7 – the industry and outsourcing opportunities; chapter 8 - R&D strengths; chapter 9 – India’s New Draft National Biotechnology Development strategy; chapter 10 – the key industry trends and opportunities; chapter 11 – strategies for the industry’s future; chapter 12 about financial strategy for emerging bio-companies and; chapter 13 gives the company profiles of key players.

1. Executive Summary
2. Biotechnology in India —An Introduction
3. Biotech Sector In India: Changing Legal Framework
3.1. Fiscal Incentives Provided to the Biotech Sector
3.2. Important Changes to the Patents Act Proposed in the Third Amendment Bill
3.3. Plant Varieties and Farmers’ Rights Protection Act, 2001
3.4. Other Regulations Impacting the Biotech Sector
3.4.1. Licensing
3.4.2. Clinical Trials
3.4.3. Seeds Act and Policy
3.4.4. Environmental Clearances
3.4.5. Biodiversity
3.5. Status on Enforcement
4. Bio-Clusters: State Driven Initiatives and Policies
4.1. Southern Region
4.2. Western Region
4.3. Northern Region
5. Indian Biotechnology Market Analysis, 2005
5.1. Total Market Size, (%) 2005
5.2. Demand for Biotech Products, (INR million) 2005-2010
5.3. Market Size by Industry Segments, (%) 2005
5.3.1. Biopharmaceuticals
5.3.1.1. Vaccines
5.3.1.2. Therapeutics
5.3.1.3. Diagnostics
5.3.2. Bioinformatics
5.3.2.1. Genomics
5.3.3. Industrial Biotech
5.3.4. Agri Biotech
5.3.4.1. GM Crops and Seeds
5.3.4.2. Bio-Fertilizers & Bio-Pesticides
5.3.4.3. Biofuels
5.3.5. Bioservices (Contract Research)
5.4. Biotech Exports, by Segment-wise, (%) 2005
5.5. Number of Companies and Associations, (in numbers) 2005
5.6. Employment Opportunities in India
5.7. Investments in Indian Biotechnology Sector, 2005
5.8. Status of Biotech Parks in India
6. SWOT Analysis of Indian Biotechnology Sector
7. India Biotechnology Industry and Outsourcing Opportunities
8. India’s Biotechnology Research and Development Strengths
9. India's New Draft National Biotechnology Development Strategy— Geared Towards Encouraging Public-Private Partnership
10. Key Industry Trends and Opportunities in Indian Biotech Industry
11. Strategies for the Indian Biotech Industry Future
11.1. Generate a National Level Resource Strength in Bioinformatics
11.2. Promote R&D Programmes in Bioinformatics
11.3. Promote Entrepreneurial Development
11.4. Globalization of the National Bioinformatics Initiatives
11.5. Encourage Development of Quality Human Resources
11.6. Restructuring the BTIS Network for Optimized Performance
12. Financial Strategy For Emerging Bio-Companies
13. Company Profiles of Key Players
13.1. Biocon
13.2. Serum Institute of India
13.3. Panacea Biotech
13.4. Nicholas Piramal
13.5. Venkateshwara Hatcheries
13.6. Wockhardt
13.7. GlaxoSmithKline
13.8. Bharat Serums
13.9. Krebs Biochemicals
13.10. Indian Immunologicals
13.11. Zydus Cadila
13.12. Shantha Biotechnics
13.13. Syngene International
13.14. Biological E
13.15. Span Diagnostics
13.16. Eli Lilly and Company
13.17. Novo Nordisk
13.18. Mahyco Monsanto
13.19. Advanta
13.20. Novozymes

List of Figures:
Figure 1. Network of national research laboratories for life sciences research
Figure 2. Total India Biotech Sales, by segment, ($ million) 2003-04 —2004-05
Figure 3. Biotech Industry Revenues, By Segment, (INR Crore) 2004-05
Figure 4. Biotech Industry Sector-wise Growth, (%) 2005
Figure 5. S&T Agencies Funding Growth for Biotechnology in India, (%) 2005
Figure 6. Exports Vs Domestic Business, (As % share within the Segment), 2004-05
Figure 7. Segment-wise Share of Total Exports & Total Domestic Business, (%) 2005
Figure 8. Employment in Indian Biotech Industry, (%) 2003-2005
Figure 9. Indian Biotechnology Market Revenue, By Regions, (INR Crore), 2005
Figure 10. Indian Biotechnology Market Revenue, Region-wise Growth, (%) 2003-04
Figure 11. Investments in Indian Biotech Industry, (%) 2002-2005
Figure 12. Growth Forecasts for the Indian Biotechnology Industry, ($ Millions) 2007-2010
Figure 13. Contract Research and Clinical Business, ($ million) 2005
Figure 14. Major Biotech Companies in Asia Pacific, (in numbers) 2005

List of Tables:
Table 1. Indian Biotechnology Industry Manpower, by Qualification, (in numbers) 2002-2005
Table 2. Biotechnology - Top 20 Players In India, ($ Million) 2004-05
Table 3. Patents Filed by Indian Companies, 2002-2003
Table 4. Products Co-Developed by Academia and Industry
Table 5. Indian Biotechnology Investment Areas, (INR Million) 2005-2010
Table 6. Status of the Biotech Parks in Different States
Table 7. All India Production of Biofertilizers, (‘000 tonnes)